Literature DB >> 19264247

Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.

Roland R J van Kimmenade1, James L Januzzi, Jaap A Bakker, Alphonse J Houben, Roger Rennenberg, Abraham A Kroon, Harry J G M Crijns, Marja P van Dieijen-Visser, Peter W de Leeuw, Yigal M Pinto.   

Abstract

OBJECTIVES: This study sought to compare the renal clearance mechanisms of B-type natriuretic peptide (BNP) and amino terminal pro-B-type natriuretic peptide (NT-proBNP).
BACKGROUND: The small molecular weight proteins (SMWPs) BNP and NT-proBNP both inversely correlate with glomerular filtration rate (GFR). Whether this association is causal or confounding is unknown and has been the basis of widespread speculation.
METHODS: We combined measurements of BNP and NT-proBNP concentrations in the renal arteries and veins of 165 subjects undergoing renal arteriography with invasive renal plasma flow (RPF) measurements and echocardiography. Fractional extraction (FE) of BNP and NT-proBNP was computed.
RESULTS: The BNP and NT-proBNP concentrations correlated similarly to GFR (r = -0.35 and r = -0.30, respectively; p < 0.001 for both) but the NT-proBNP/BNP serum ratio was negatively associated with GFR (r = -0.21, p = 0.008). Median FE(BNP) was 0.21 (interquartile range [IQR] 0.16 to 0.22) for left and 0.22 (IQR 0.17 to 0.29) for right kidneys. Median FE(NT-proBNP) was 0.16 (IQR 0.09 to 20) for left and 0.18 (IQR 0.12 to 0.22) for right kidneys. The FE(BNP) correlated with GFR (left: r = 0.26, p = 0.008; right: r = 0.21, p = 0.03) as did FE(NT-proBNP) (left: r = 0.25, p = 0.005; right: r = 0.20, p = 0.02). Although FE(BNP) and FE(NT-proBNP) correlated strongly with each other (left: r = 0.66; right: r = 0.60; p < 0.001 for both), left and right FE(NT-proBNP/BNP) ratios were not influenced by GFR (r = 0.10, p = 0.30 and r = 0.08, p = 0.43, respectively). Multivariate analyses confirmed that FE was not independently associated with BNP or NT-proBNP concentrations.
CONCLUSIONS: Contrary to widespread belief (but in line with the renal physiology of SMWP), BNP and NT-proBNP are equally dependent on renal function for their clearance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264247     DOI: 10.1016/j.jacc.2008.11.032

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  48 in total

Review 1.  Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.

Authors:  Stephen A Hill; Ronald A Booth; P Lina Santaguida; Andrew Don-Wauchope; Judy A Brown; Mark Oremus; Usman Ali; Amy Bustamam; Nazmul Sohel; Robert McKelvie; Cynthia Balion; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

2.  Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?

Authors:  Yuan-Hui Liu; Lei Jiang; Ji-Yan Chen; Ning Tan; Yong Liu; Peng Cheng He
Journal:  Int Urol Nephrol       Date:  2016-07-29       Impact factor: 2.370

Review 3.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

4.  Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement.

Authors:  Roman Pfister; Thorsten Wahlers; Frank M Baer; Max Scherner; Justus Strauch; Erland Erdmann
Journal:  Clin Res Cardiol       Date:  2010-02-06       Impact factor: 5.460

5.  A multi-marker approach to predict incident CKD and microalbuminuria.

Authors:  Caroline S Fox; Philimon Gona; Martin G Larson; Jacob Selhub; Geoffrey Tofler; Shih-Jen Hwang; James B Meigs; Daniel Levy; Thomas J Wang; Paul F Jacques; Emelia J Benjamin; Ramachandran S Vasan
Journal:  J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 10.121

6.  In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.

Authors:  Yuxiang Dai; Jun Yang; Atsutoshi Takagi; Hakuoh Konishi; Tetsuro Miyazaki; Hiroshi Masuda; Kazunori Shimada; Katsumi Miyauchi; Hiroyuki Daida
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

7.  Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.

Authors:  Meyeon Park; Eric Vittinghoff; Michael G Shlipak; Rakesh Mishra; Mary Whooley; Nisha Bansal
Journal:  Am Heart J       Date:  2014-10-14       Impact factor: 4.749

8.  Diagnostic value of novel biomarkers for heart failure : A meta-analysis.

Authors:  Z Huang; J Zhong; Y Ling; Y Zhang; W Lin; L Tang; J Liu; S Li
Journal:  Herz       Date:  2018-04-26       Impact factor: 1.443

9.  Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure.

Authors:  Keizo Toda; Yukihito Sato; Tomoko Hara; Kenro Hijiya; Ryutaro Kaneko; Tatuo Okada; Yoshiki Takatsu; Hisayoshi Fujiwara; Toshiaki Iwasaki
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

10.  Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.

Authors:  Gerd Bodlaj; Rainer Hubmann; Karim Saleh; Georg Biesenbach; Erich Pohanka; Tatjana Stojakovic; Jörg Berg
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.